HOME >> MEDICINE >> NEWS
Other highlights in the October 15 issue of JNCI

Study Confirms Risk Factors for Malignant Melanoma

A new study confirms previous findings that hair color, number of moles on the legs, and history of sunburn are risk factors for malignant melanoma. The study also found that the use of sunbeds and other tanning devices is associated with an increased risk of the disease. Marit Veierd, Ph.D., of the University of Oslo in Norway, and colleagues surveyed 106,379 Norwegian and Swedish women between the ages of 30 and 50 about their personal characteristics and exposures. During an average follow-up of 8.1 years, there were 187 cases of melanoma diagnosed among these women. Melanoma risk was associated with increasing body surface area; the number of large asymmetric moles on the legs; having naturally red hair; the number of sunburns per year during the second, third, and fourth decades of life; and use one or more times per month of artificial tanning lights. The authors also note that the strongest effects of UV exposure on melanoma risk appear to be during adolescence and early adulthood.

Low White Cell Counts May Affect Breast Cancer Outcomes Among African American Women

African American women with early-stage breast cancer have lower baseline white blood cell counts and therefore appear to have delays in doses of adjuvant chemotherapy compared with white women with early-stage breast cancer. The treatment delays may explain racial differences in breast cancer survival, authors of a new study suggest. Dawn Hershman, M.D., of the New York-Presbyterian Hospital in New York, and her colleagues collected information on 73 African American and 126 matched white women, and of these women, 43 white and 93 African American women had undergone adjuvant chemotherapy. They found that African American women had lower white blood cell counts at baseline and after treatment and required a longer treatment duration (19 weeks versus 15 weeks). "This difference in dose intensity may contribute to t
'"/>

Contact: Linda Wang
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
31-Dec-2000


Page: 1 2 3

Related medicine news :

1. Other highlights in the March 16 JNCI
2. Other highlights in the March 2 JNCI
3. Other highlights in the February 2 JNCI
4. Other highlights in the January 19 JNCI
5. Other highlights in the December 15 JNCI
6. Other highlights in the December 1 JNCI
7. Other highlights in the September 15 JNCI
8. Other highlights in the April 21 JNCI
9. Other highlights in the April 7 JNCI
10. Other highlights in the January 7 issue of JNCI
11. Other highlights in the December 3 issue of JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Cut Pro X users can now reveal the media of their split screens ...
(Date:6/27/2016)... ... ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology:
Cached News: